Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02406508
Title Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Delcath Systems Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa Florida 33612 United States Details
Montefiore Medical Center New York New York 10467 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field